Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis

[1]  R. Bataille,et al.  Single versus double autologous stem-cell transplantation for multiple myeloma. , 2003, The New England journal of medicine.

[2]  Dirk Hasenclever,et al.  Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial , 2002, The Lancet.

[3]  H. Goldschmidt,et al.  Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy. , 2001, Blood.

[4]  G. Perea,et al.  Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma , 2001, Annals of Hematology.

[5]  C. Klersy,et al.  Blood stem cell collections in multiple myeloma: definition of a scoring system , 2000, Bone Marrow Transplantation.

[6]  F. Hernández-Navarro,et al.  Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation. , 2000, Journal of hematotherapy & stem cell research.

[7]  P. Wernet,et al.  Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma , 1999, Annals of Hematology.

[8]  A. Ho,et al.  Peripheral blood progenitor cell (PBPC) counts during steady‐state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony‐stimulating factor supported cytotoxic chemotherapy: an update on 100 patients , 1999, British journal of haematology.

[9]  P. Cony-Makhoul,et al.  Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study , 1998, Leukemia.

[10]  N. Kröger,et al.  Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone , 1998, Annals of Hematology.

[11]  B. Sautois,et al.  Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells , 1998, Transfusion.

[12]  H. Goldschmidt,et al.  Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma , 1997, British journal of haematology.

[13]  J. Rossi,et al.  A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma , 1996 .

[14]  R. Storb,et al.  Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. , 1996, Bone marrow transplantation.

[15]  R. Storb,et al.  High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Goldschmidt,et al.  Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma. , 1996, Bone marrow transplantation.

[17]  J. Meharchand,et al.  Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections , 1996, British journal of haematology.

[18]  N. Schmitz,et al.  Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. , 1995, Blood.

[19]  R. Storb,et al.  Factors that influence collection and engraftment of autologous peripheral-blood stem cells. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J Sullivan,et al.  Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[21]  B. Barlogie,et al.  Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. , 1995, Blood.

[22]  H. Goldschmidt,et al.  Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. , 1994, Blood.

[23]  D. Williamson,et al.  The box plot: a simple visual method to interpret data. , 1989, Annals of internal medicine.

[24]  M. Tubiana,et al.  Late effects on human bone marrow after extended field radiotherapy. , 1983, International journal of radiation oncology, biology, physics.

[25]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.

[26]  S Landman,et al.  Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease , 1973, Cancer.

[27]  H. Wilson,et al.  Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. , 1969, JAMA.

[28]  H. Atkinson.  Bone marrow distribution as a factor in estimating radiation to the blood-forming organ: a survey of present knowledge. , 1962, Journal of the College of Radiologists of Australasia.

[29]  M. Kricun.  Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions , 2004, Skeletal Radiology.

[30]  J. Rossi,et al.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. , 1996, The New England journal of medicine.

[31]  A. Santoro,et al.  Mobilization of circulating progenitor cells in multiple myeloma during VCAD therapy with or without rhG-CSF. , 1995, Haematologica.

[32]  R. E. Ellis,et al.  The distribution of active bone marrow in the adult. , 1961, Physics in medicine and biology.